The antioxidative activity of oral hypoglycemic agents
نویسندگان
چکیده
منابع مشابه
The use of oral hypoglycemic agents.
This DESG Teaching Letter was written by the DESG Executive commitee: Executive commitee: Dr. J.M. BOAVIDA, MD, Lisbon – Portugal (President); Dr. A. BROOKS, MD, Winchester – UK (Vice-President); Dr. I. HARMAN-BOEHM, MD, Sheva – Israel. (Director Educational Strategies); Ms. D. VARAKLA, Athens – Greece (Honorary Secretary); Dr. A. BALDELLI, MD, Rome – Italy (Honorary Treasurer); Dr. R. CHLUP, M...
متن کاملAdherence to Oral Hypoglycemic Agents in Hawaii
INTRODUCTION Adherence to oral hypoglycemic agents is essential to reducing the poor health outcomes of populations at high risk for developing diabetes and its chronic complications. The goal of this study was to identify characteristics of patients in Hawaii least likely to adhere to oral hypoglycemic agents. METHODS This retrospective administrative data analysis included prescription refi...
متن کاملOral Hypoglycemic Agents in pregnancy: An Update.
INTRODUCTION Traditionally, insulin has been the gold standard in the management of Type 2 diabetes in pregnancy and gestational diabetes. However, insulin therapy can be inconvenient because of the needs for multiple injections, its associated cost, pain at the injection site, need for refrigeration, and skillful handling of the syringes. This has led to the exploration of oral hypoglycemic ag...
متن کاملOral hypoglycemic agents: do the ends justify the means?
BACKGROUND Glyburide has replaced insulin as the first line of therapy in the treatment of gestational diabetes in the United States. Glyburide and metformin therapies were reported to be comparable to insulin yet also cost-effective, patient-friendly, and potentially compliance-enhancing. Recently, the efficacy of the use of these oral hypoglycemic drugs has been questioned. In this review, th...
متن کاملHypoglycemic agents and potential anti-inflammatory activity.
Current literature shows an association of diabetes and secondary complications with chronic inflammation. Evidence of these immunological changes include altered levels of cytokines and chemokines, changes in the numbers and activation states of various leukocyte populations, apoptosis, and fibrosis during diabetes. Therefore, treatment of diabetes and its complications may include pharmacolog...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Problems of Endocrinology
سال: 2011
ISSN: 2308-1430,0375-9660
DOI: 10.14341/probl201157421-24